Hepatic Artery Infusion Therapy Now at Jersey Shore University

What You Need To Know

• Patients who are diagnosed with metastatic colorectal cancer or cholangiocarcinoma now have close-to-home access to the only FDA-approved pump for hepatic artery infusion (HAI) therapy at Jersey Shore University.
• HAI therapy provides a new option for patients that extends survival and improves tumor resectability while reducing chemotherapy-related toxicity and enhancing quality of life.

The Intera 3000 Hepatic Artery Infusion Pump administers chemotherapy directly to tumors in the liver, resulting in a drug concentration in the tumors that is up to 400 times greater than concentrations achieved with conventional intravenous chemotherapy without the negative side effects. Jersey Shore is one of only two centers in New Jersey — and only a few in the U.S. — to offer this lifesaving, liver-directed therapeutic option.

Referring your patients to Jersey Shore University for HAI therapy may provide benefits that include:

• Reduced toxicity due to direct administration to the liver and minimal systemic exposure
• Improved response rate due to higher drug concentration in tumors
• Making surgical resection possible by shrinking tumors after neoadjuvant use
• Preventing or delaying the recurrence of tumors after surgical removal
• Enhanced survival with an improved quality of life

For More Information

To refer a patient, please call 732-776-4770.